Formosa Pharmaceuticals, Inc. (TPE:6838)
24.30
+0.15 (0.62%)
At close: Jul 9, 2026
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 3.67 billion as of July 9, 2026. Its market cap has decreased by -31.93% in one year.
Market Cap
3.67B
Enterprise Value
2.31B
Revenue
54.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.30
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 3.67B, a decrease of -33.71%. That is a compound annual growth rate of -8.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.67B | -7.95% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OBI Pharma | 3.94B |
| Senhwa Biosciences | 3.91B |
| Genovate Biotechnology | 3.88B |
| Sagittarius Life Science | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.29B |
| Energenesis Biomedical CO.,LTD. | 3.23B |
| BioGend Therapeutics | 3.19B |
| Shine-On BioMedical | 3.19B |